Militia Capital Partners LP Takes Position in Molina Healthcare, Inc $MOH

Militia Capital Partners LP purchased a new stake in shares of Molina Healthcare, Inc (NYSE:MOH) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,000 shares of the company’s stock, valued at approximately $1,909,000.

Several other hedge funds and other institutional investors also recently modified their holdings of MOH. AQR Capital Management LLC boosted its holdings in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the period. 8 Knots Management LLC acquired a new position in shares of Molina Healthcare during the fourth quarter valued at $198,942,000. Victory Capital Management Inc. boosted its holdings in shares of Molina Healthcare by 344.3% during the third quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock valued at $184,380,000 after acquiring an additional 746,639 shares during the period. Norges Bank acquired a new position in shares of Molina Healthcare during the fourth quarter valued at $109,766,000. Finally, Baupost Group LLC MA acquired a new position in shares of Molina Healthcare during the fourth quarter valued at $108,463,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by corporate insiders.

Molina Healthcare Stock Performance

MOH stock opened at $200.08 on Wednesday. The company has a market capitalization of $10.42 billion, a P/E ratio of 59.19 and a beta of 0.80. The company has a 50-day simple moving average of $177.24 and a 200 day simple moving average of $165.38. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $311.52. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the prior year, the company posted $6.08 earnings per share. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts predict that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on MOH. Morgan Stanley boosted their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a report on Thursday, June 4th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a report on Monday, June 8th. Robert W. Baird upped their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a report on Tuesday, April 21st. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $182.73.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.